Segments Covered in the Report By Product Type Injectables: [Exenatide(Byetta, Bydureon), Liraglutide(Victoza, Saxenda), Semaglutide(Ozempic, Wegovy), Dulaglutide(Trulicity), Lixisenatide(Lyxumia), Albiglutide (Eperzan)] Oral GLP-1 Receptor Agonists: [Rybelsus (Semaglutide oral)] By Application Type 2 Diabetes Management Obesity and Weight Management Cardiovascular Diseases (CV) By End User Hospitals Clinics Retail Pharmacies Homecare/Direct-to-Patient By Distribution Channel Retail Pharmacies Online Pharmacies Hospitals & Clinics Set up a meeting at your convenience to get more insights instantly!
The strongest evidence for meaningful, long-term weight loss and cardiometabolic benefit is at the labeled maintenance doses reached using a slow, individualized titration
2025, doi: 10.3949/ccjm.92a.24113
At JosephCareRX, we incorporate GLP-1-based medications as part of individualized treatment plans for patients struggling with obesity, type 2 diabetes, or metabolic syndrome
Wear nightly for optimal enamel protection
